Carla Avallone
Biographic Data
| ID | 7872011 |
|---|---|
| NAME | Carla Avallone |
| GIVEN NAMES | Carla |
| FAMILY NAME | Avallone |
| SIGNATURE | AVALLONE C |
| AFFILIATIONS | Università Cattolica del Sacro Cuore |
| ORCID | 0000-0003-2664-3023 |
| VERIFIED | Yes |
| TOTAL WORKS | 1 |
| TOTAL CITATIONS | 0 |
| AUTHOR COUNT | 1 |
| EDITOR COUNT | 0 |
| FIRST PUBLICATION YEAR | 2022 |
| LATEST PUBLICATION YEAR | 2022 |
| H-INDEX | 0 |
Trazodone Prolonged-Release Monotherapy in Cannabis Dependent Patients during Lockdown Due to Covid-19 Pandemic: A Case Series
(1) Background: During the SARS-CoV-2 (COVID-19) pandemic, cannabis use increased relative to pre-pandemic levels, while forced home confinement frequently caused sleep/wake cycle disruptions, psychological distress, and maladaptive coping strategies with the consequent appearance of anxiety symptoms and their potential impact on substance use problems. (2) Aim: Long-acting trazodone (150 mg or 300 mg daily) has a potential benefit as monotherapy…
No prominent works on this page.
Trazodone Prolonged-Release Monotherapy in Cannabis Dependent Patients during Lockdown Due to Covid-19 Pandemic: A Case Series
(1) Background: During the SARS-CoV-2 (COVID-19) pandemic, cannabis use increased relative to pre-pandemic levels, while forced home confinement frequently caused sleep/wake cycle disruptions, psychological distress, and maladaptive coping strategies with the consequent appearance of anxiety symptoms and their potential impact on substance use problems. (2) Aim: Long-acting trazodone (150 mg or 300 mg daily) has a potential benefit as monotherapy…
Addiction (1 works) · Adverse effect (1 works) · Antidepressant (1 works) · Anxiety (1 works) · Bipolar Disorder and Treatment (1 works) · Cannabidiol (1 works) · Cannabis (1 works) · Cannabis and Cannabinoid Research (1 works) · Cannabis Dependence (1 works) · Clinical Psychology (1 works)